TARPLIN, DOWNS & YOUNG, LLC

Lobbying for CRINETICS PHARMACEUTICALS · Pharmaceutical and therapeutic company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

innovation, prescription drug pricing

Medicare/Medicaid

Medicare policy

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.